Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
DOSING REGIMEN FOR PONESIMOD, A SELECTIVE S1P1 RECEPTOR AGONIST

No-Receipt date 2022-01682 - 10/05/2022
No-Filing date 20220800016 - 10/05/2022
No-Granting date 8000930 - 23/05/2023
No-EPO application date -
No-EPO granting date -
Gazette No-Publication date of application 9/2022 - 10/10/2022
Gazette No-Publication date of granted patent 5/2023 - 13/06/2023
Expiration date 22/05/2036
Kind of title Supplementary Protection Certificate for Medicinal Products
Legal status VALID
Priorities -
Active Substance of Supplementary Certificates PONESIMOD ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΩΣ ΑΠΟΔΕΚΤΑ ΑΛΑΤΑ ΑΥΤΗΣ

IPC Classification

Related Documents

Related Titles
TypeMaster titleRelated title
[SPC] 20220400767

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1402021 ACTELION PHARMACEUTICALS LTD GEWERBESTRASSE 164123 ALLSCHWIL SWITZERLAND

Inventors
CodeFirstnameSurname
3611234 DINGEMANSE, JASPER
3611235 HOCH, MATTHIAS
3611236 KRAUSE, ANDREAS

Representatives
CodeFirstnameSurnameAddressTownZip
3190KONSTANTINOSKILIMIRIS "PATRINOS & KILIMIRIS DIKIGORIKI ETAIRIA"CHATZIGIANNI MEXI 7ATHINA (ATTIKIS)11528

Contact
CodeFirstnameSurnameAddressTownZipCountry
8149KONSTANTINOSKILIMIRISCHATZIGIANNI MEXI 7ATHINA (ATTIKIS)11528 GREECE

Owners History

Title Instruments

Payments history
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015